Read More Pharma Industry News ESTEVE acquires Caprelsa from Sanofi to boost rare cancer drug portfolio and global specialty focus ESTEVE is acquiring Caprelsa® from Sanofi to expand its rare cancer drug portfolio. The deal boosts ESTEVE's focus on highly specialized treatments. byPallavi MadhirajuJuly 2, 2025